Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,696,503
+$588,315 QoQ
Shares Held
214,205
+12.1% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 238 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. XERS ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in XERS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,696,503 | 214,205 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,108,188 | 191,067 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,488,100 | 189,567 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,739,876 | 213,744 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,007,276 | 215,691 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,055,622 | 192,281 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $613,467 | 180,964 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $494,634 | 173,556 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $427,432 | 189,970 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $392,579 | 177,638 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $402,536 | 171,292 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $323,282 | 173,808 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $455,589 | 173,889 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $281,747 | 172,851 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $220,595 | 165,861 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $253,836 | 162,716 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $233,485 | 151,614 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||